BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15224907)

  • 1. [Controlling tumor pain with delayed-action opioids. Better quality of life with effective pain treatment].
    MMW Fortschr Med; 2004 Apr; 146(17):48-9. PubMed ID: 15224907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study].
    Sittig HB
    MMW Fortschr Med; 2004 Dec; 146(49):45. PubMed ID: 15646717
    [No Abstract]   [Full Text] [Related]  

  • 3. [General practice study reveals simplification of therapy for physician and patients. Patient satisfaction and better quality of life].
    MMW Fortschr Med; 2007 Nov; 149(48):51. PubMed ID: 18163263
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tolerated opioid therapy with oxycodone/naloxone. Better quality of life for osteoporosis patients].
    MMW Fortschr Med; 2009 Apr; 151(18):27. PubMed ID: 19769067
    [No Abstract]   [Full Text] [Related]  

  • 5. [Delayed action and rapidly effective in combination. Hydromorphone--already a WHO stage 3 drug].
    MMW Fortschr Med; 2006 May; 148(19):47. PubMed ID: 16736708
    [No Abstract]   [Full Text] [Related]  

  • 6. [Better quality of life for tumor patients].
    Krankenpfl J; 2004; 42(1-2):20. PubMed ID: 15116771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Individual aspects of the quality of life of patients with chronic pain. Observational study of treatment with fentanyl-TTS].
    Zimmermann M; Waap I
    MMW Fortschr Med; 2005 Apr; 147 Suppl 1():33-40. PubMed ID: 16739370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled-release hydromorphone in elderly patients with severe pain of different etiologies. Results of an observational study].
    Junker U; Figge V
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():91-6. PubMed ID: 16261943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic management of cancer pain.
    Levy MH
    Semin Oncol; 1994 Dec; 21(6):718-39. PubMed ID: 7527595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic opioid therapy for nonmalignant pain: the patient's perspective. Part I--life before and after opioid therapy.
    Vallerand A; Nowak L
    Pain Manag Nurs; 2009 Sep; 10(3):165-72. PubMed ID: 19706354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observational data in elderly pain patients show that fear of opioid therapy is unfounded].
    Junker U; Figge V
    MMW Fortschr Med; 2005 Jul; 147(27-28):43. PubMed ID: 16041941
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analgesia with opioids. Pain therapy is standardized care].
    Koczorek M
    MMW Fortschr Med; 2003 Oct; 145(41):12. PubMed ID: 14655470
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids for metastatic bone pain.
    Hara S
    Oncology; 2008; 74 Suppl 1():52-4. PubMed ID: 18758198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimized opioid therapy of chronic pain. Constant plasma level versus chronoadjusted analgesia].
    Von Sabatowski R; Grond S; Blume H
    MMW Fortschr Med; 2010 Apr; 152 Suppl 1():12-5. PubMed ID: 20942302
    [No Abstract]   [Full Text] [Related]  

  • 16. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization.
    Jensen MK; Thomsen AB; Højsted J
    Eur J Pain; 2006 Jul; 10(5):423-33. PubMed ID: 16054407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study].
    Sittig HB
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):95-8. PubMed ID: 15662898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New morphine preparations with extended effect duration. 2 treatment observations].
    Kim DJ; Jankowska H; Dierke-Dzierzon C; Sturm M; Lindena G
    MMW Fortschr Med; 2000 May; 142(18):49. PubMed ID: 10851871
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parenteral opioids in end-of-life care in cancer patients].
    Hattori S; Kimura N; Takatani J; Noguchi T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):161-6. PubMed ID: 15751626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ambulatory pain therapy for tumor patients. Carefully titrating opiates, anticipating side-effects!].
    Tamm R
    MMW Fortschr Med; 2004 Apr; 146(17):18. PubMed ID: 15224899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.